CoChat

The views of health guideline developers on the use of automation in health evidence synthesis

Open access

Published version of a preprint

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index; 3 of the 19 sources its claims cite were checked for support.

Abstract

Background: The increasingly rapid rate of evidence publication has made it difficult for evidence synthesis—systematic reviews and health guidelines—to be continually kept up to date. One proposed solution for this is the use of automation in health evidence synthesis. Guideline developers are key gatekeepers in the acceptance and use of evidence, and therefore, their opinions on the potential use of automation are crucial. Methods: The objective of this study was to analyze the attitudes of guideline developers towards the use of automation in health evidence synthesis. The Diffusion of Innovations framework was chosen as an initial analytical framework because it encapsulates some of the core issues which are thought to affect the adoption of new innovations in practice. This well-established theory posits five dimensions which affect the adoption of novel technologies: Relative Advantage , Compatibility , Complexity , Trialability , and Observability . Eighteen interviews were conducted with individuals who were currently working, or had previously worked, in guideline development. After transcription, a multiphase mixed deductive and grounded approach was used to analyze the data. First, transcripts were coded with a deductive approach using Rogers’ Diffusion of Innovation as the top-level themes. Second, sub-themes within the framework were identified using a grounded approach. Results: Participants were consistently most concerned with the extent to which an innovation is in line with current values and practices (i.e., Compatibility in the Diffusion of Innovations framework). Participants were also concerned with Relative Advantage and Observability , which were discussed in approximately equal amounts. For the latter, participants expressed a desire for transparency in the methodology of automation software. Participants were noticeably less interested in Complexity and Trialability , which were discussed infrequently. These results were reasonably consistent across all participants. Conclusions: If machine learning and other automation technologies are to be used more widely and to their full potential in systematic reviews and guideline development, it is crucial to ensure new technologies are in line with current values and practice. It will also be important to maximize the transparency of the methods of these technologies to address the concerns of guideline developers.

Overview

CoChat Summary

TL;DR

This qualitative interview study analyzed guideline developers’ attitudes toward automation in health evidence synthesis using Rogers’ Diffusion of Innovations framework. Compatibility with professional values was the dominant concern, followed by Relative Advantage and Observability, while Complexity and Trialability were discussed least.

Key findings

  • Across 18 interviews, Compatibility was the most prominently discussed theme; Relative Advantage and Observability were discussed in approximately equal amounts, and Complexity and Trialability were discussed infrequently.
  • Within Compatibility, participants emphasized the ability to double-check automation output with human input and transparency as accountability, including freely accessible and examinable automation methods.
  • Relative Advantage centered on freeing up human resources, with less emphasis on time and cost saving; no participants indicated openness to any trade-off between accuracy and time.
  • Observability involved a need for rigorous evidence before adoption and ongoing ability to check machine-learning processes; contextual themes included low participant familiarity with automation and overall skepticism toward machine learning.

Methods

  • Semi-structured one-on-one interviews were conducted via phone or Skype with 18 individuals currently or previously working in guideline development; 20 responded, and 2 were ineligible due to lack of firsthand guideline development experience.
  • Participants were purposively sampled through personal and professional networks, including Guidelines International Network, NICE, and NHMRC.
  • Transcripts were verbatim transcribed, participant-validated, and analyzed in QSR NVivo 12 using a thematic approach adapted for deductive and inductive analysis: Rogers’ Diffusion of Innovations provided top-level themes, followed by grounded open coding, theme generation, matrices, and identification of patterns and outliers.

Limitations

  • The paper states that purposive sampling resulted in 18 participants from a relatively small number of organizations, with possible bias toward similar respondents; the sample was 28% male and over-represented Australian professionals (11 Australia, 7 USA/UK), though the authors note consistency in data suggested additional data might not change results.
  • The paper states that the field appears to be in very early stages of broader adoption (innovators), so later studies may return different results; participants often reported feeling inexperienced with automation.
  • Evident from the text: the study relies on self-reported views and does not directly test automation tools or observe guideline development workflows.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13643-020-01569-2

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Summary of results
Fig. 1 Summary of resultsCC BY · PubMed Central
Fig. 2 Diffusion of Innovations adoption curve and market share
Fig. 2 Diffusion of Innovations adoption curve and market shareCC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 0 Not valid · 12 Not checked · 73 Own results and interpretations

24 more claims

Create a free account to see all 87 claims and to verify the 16 references still open.

See all claims — free account
  • Probably not a substantial claim. 46
  • It may state two separate claims as one. 27
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 16 references

Research works printed but not linked: 2

  1. Rogers. E.M. Simon and Schuster: Diffusion of innovations; 2010.
  2. Braun V, Clarke V, Terry G. Thematic analysis. Qual Res Clin Health Psychol. 2014;24:95–114.

Cited by

See all 40

Metadata

Authors
Arno, A., Elliott, J., Wallace, B., Turner, T., & Thomas, J.
Affiliations
  • University College London (GB)
  • Monash University (AU)
  • Northeastern University (US)
Corresponding author
Arno, Anneliese
Venue
Systematic Reviews
Published
2021-01-08
Volume
10
Issue
1
Pages
16-16
ISSN
2046-4053 (ISSN-L)
OpenAlex
W3120256265
Cited by
40
References
16
Citations by year
2026: 3 · 2025: 6 · 2024: 4 · 2023: 10 · 2022: 10 · 2021: 7
FWCI
6.67
Type
journal article
Language
en
Open access
Licence
Locations
  • Systematic Reviews (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
Funders
Joint UCL and Monash PhD Studentship
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
technology adoption, machine learning, compatibility, relative advantage, observability
MeSH terms
Systematic Reviews as Topic, Automation, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The views of health guideline developers on the use of automation in health evidence synthesis. https://app.cochat.ai/papers/10.1186/s13643-020-01569-2
The paper
Arno, A., Elliott, J., Wallace, B., Turner, T., & Thomas, J. (2021). The views of health guideline developers on the use of automation in health evidence synthesis. Systematic Reviews. https://doi.org/10.1186/s13643-020-01569-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.